Determinants of improvement trends in health workers' compliance with outpatient malaria case-management guidelines at health facilities with available "test and treat" commodities in Kenya.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 22 12 2020
accepted: 11 10 2021
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 28 12 2021
Statut: epublish

Résumé

Health workers' compliance with outpatient malaria case-management guidelines has been improving in Africa. This study examined the factors associated with the improvements. Data from 11 national, cross-sectional health facility surveys undertaken from 2010-2016 were analysed. Association between 31 determinants and improvement trends in five outpatient compliance outcomes were examined using interactions between each determinant and time in multilevel logistic regression models and reported as an adjusted odds ratio of annual trends (T-aOR). Among 9,173 febrile patients seen at 1,208 health facilities and by 1,538 health workers, a higher annual improvement trend in composite "test and treat" performance was associated with malaria endemicity-lake endemic (T-aOR = 1.67 annually; p<0.001) and highland epidemic (T-aOR = 1.35; p<0.001) zones compared to low-risk zone; with facilities stocking rapid diagnostic tests only (T-aOR = 1.49; p<0.001) compared to microscopy only services; with faith-based/non-governmental facilities compared to government-owned (T-aOR = 1.15; p = 0.036); with a daily caseload of >25 febrile patients (T-aOR = 1.46; p = 0.003); and with under-five children compared to older patients (T-aOR = 1.07; p = 0.013). Other factors associated with the improvement trends in the "test and treat" policy components and artemether-lumefantrine administration at the facility included the absence of previous RDT stock-outs, community health workers dispensing drugs, access to malaria case-management and Integrated Management of Childhood Illness (IMCI) guidelines, health workers' gender, correct health workers' knowledge about the targeted malaria treatment policy, and patients' main complaint of fever. The odds of compliance at the baseline were variable for some of the factors. Targeting of low malaria risk areas, low caseload facilities, male and government health workers, continuous availability of RDTs, improving health workers' knowledge about the policy considering age and fever, and dissemination of guidelines might improve compliance with malaria guidelines. For prompt treatment and administration of the first artemether-lumefantrine dose at the facility, task-shifting duties to community health workers can be considered.

Sections du résumé

BACKGROUND
Health workers' compliance with outpatient malaria case-management guidelines has been improving in Africa. This study examined the factors associated with the improvements.
METHODS
Data from 11 national, cross-sectional health facility surveys undertaken from 2010-2016 were analysed. Association between 31 determinants and improvement trends in five outpatient compliance outcomes were examined using interactions between each determinant and time in multilevel logistic regression models and reported as an adjusted odds ratio of annual trends (T-aOR).
RESULTS
Among 9,173 febrile patients seen at 1,208 health facilities and by 1,538 health workers, a higher annual improvement trend in composite "test and treat" performance was associated with malaria endemicity-lake endemic (T-aOR = 1.67 annually; p<0.001) and highland epidemic (T-aOR = 1.35; p<0.001) zones compared to low-risk zone; with facilities stocking rapid diagnostic tests only (T-aOR = 1.49; p<0.001) compared to microscopy only services; with faith-based/non-governmental facilities compared to government-owned (T-aOR = 1.15; p = 0.036); with a daily caseload of >25 febrile patients (T-aOR = 1.46; p = 0.003); and with under-five children compared to older patients (T-aOR = 1.07; p = 0.013). Other factors associated with the improvement trends in the "test and treat" policy components and artemether-lumefantrine administration at the facility included the absence of previous RDT stock-outs, community health workers dispensing drugs, access to malaria case-management and Integrated Management of Childhood Illness (IMCI) guidelines, health workers' gender, correct health workers' knowledge about the targeted malaria treatment policy, and patients' main complaint of fever. The odds of compliance at the baseline were variable for some of the factors.
CONCLUSIONS
Targeting of low malaria risk areas, low caseload facilities, male and government health workers, continuous availability of RDTs, improving health workers' knowledge about the policy considering age and fever, and dissemination of guidelines might improve compliance with malaria guidelines. For prompt treatment and administration of the first artemether-lumefantrine dose at the facility, task-shifting duties to community health workers can be considered.

Identifiants

pubmed: 34739519
doi: 10.1371/journal.pone.0259020
pii: PONE-D-20-40255
pmc: PMC8570506
doi:

Substances chimiques

Antimalarials 0
Artemether, Lumefantrine Drug Combination 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0259020

Subventions

Organisme : Wellcome Trust
ID : 212176
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103602
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Organisme : EPA
ID : EP-C-15-003
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107769/Z/10/Z
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Malar J. 2012 Jul 02;11:221
pubmed: 22747655
BMC Med. 2015 May 15;13:118
pubmed: 25980737
Malar J. 2017 May 3;16(1):186
pubmed: 28468663
Malar J. 2013 Sep 21;12:334
pubmed: 24053679
Malar J. 2010 Aug 22;9:240
pubmed: 20727214
BMJ Open. 2017 Mar 8;7(3):e012973
pubmed: 28274962
Malar J. 2008 Sep 19;7:181
pubmed: 18803833
Bull World Health Organ. 2008 Feb;86(2):101-10
pubmed: 18297164
BMC Health Serv Res. 2019 Oct 22;19(1):735
pubmed: 31640676
Malar J. 2017 May 25;16(1):221
pubmed: 28545579
Malar J. 2014 Dec 18;13:508
pubmed: 25518838
BMC Med Res Methodol. 2002 Jun 17;2:8
pubmed: 12069695
Health Policy Plan. 2015 Nov;30(9):1129-41
pubmed: 25339637
PLoS One. 2011;6(9):e24781
pubmed: 21935464
BMC Health Serv Res. 2015 Jul 21;15:276
pubmed: 26194895
Malar J. 2017 Jan 23;16(1):40
pubmed: 28114942
PLoS One. 2017 Mar 2;12(3):e0173093
pubmed: 28253315
Lancet Glob Health. 2014 Jun;2(6):e346-58
pubmed: 25103303
PLoS One. 2014 Mar 24;9(3):e92782
pubmed: 24663961
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):128-32
pubmed: 18165484
PLoS One. 2014 Feb 20;9(2):e89050
pubmed: 24586497
Malar J. 2014 Feb 20;13:64
pubmed: 24555546
Malar J. 2016 Feb 24;15:112
pubmed: 26911252
Am J Infect Control. 2018 Nov;46(11):1211-1217
pubmed: 29866633
Am J Trop Med Hyg. 2018 Sep;99(3):670-679
pubmed: 29943717
Lancet. 1999 Sep;354 Suppl 2:SII16-20
pubmed: 10507254
Cochrane Database Syst Rev. 2011 Sep 07;(9):CD006413
pubmed: 21901704
Hum Resour Health. 2010 Mar 31;8:8
pubmed: 20356363
JAMA Pediatr. 2015 Apr;169(4):349-57
pubmed: 25686357
Bull World Health Organ. 1997;75 Suppl 1:7-24
pubmed: 9529714
Malar J. 2010 Sep 18;9:261
pubmed: 20849650
Health Aff (Millwood). 2016 Sep 1;35(9):1716-24
pubmed: 27605655
Malar J. 2011 Dec 19;10:372
pubmed: 22182735
Malar J. 2016 Mar 15;15:163
pubmed: 26979286
BMC Public Health. 2012 Jan 06;12:11
pubmed: 22221821
Glob Health Action. 2017;10(1):1413266
pubmed: 29261450
BMJ. 2020 Apr 22;369:m1176
pubmed: 32321709
Malar J. 2020 Nov 11;19(1):406
pubmed: 33176783
Am J Trop Med Hyg. 2017 Oct;97(4):1170-1179
pubmed: 28820705
Implement Sci. 2019 Mar 4;14(1):20
pubmed: 30832678
Malar J. 2011 May 20;10:136
pubmed: 21599880
Malar J. 2013 Aug 26;12:293
pubmed: 23977904
Lancet. 2008 Sep 13;372(9642):910-6
pubmed: 18790314
Malar J. 2018 Nov 19;17(1):432
pubmed: 30454044
Cost Eff Resour Alloc. 2009 Apr 08;7:5
pubmed: 19356225
Health Aff (Millwood). 2007 May-Jun;26(3):w380-92
pubmed: 17389635
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799
BMC Health Serv Res. 2019 Jul 24;19(1):516
pubmed: 31340809
Trop Med Int Health. 2008 Mar;13(3):369-83
pubmed: 18397400
PLoS One. 2017 Mar 13;12(3):e0170998
pubmed: 28288172
PLoS One. 2013 Jun 12;8(6):e66030
pubmed: 23776599
PLoS One. 2018 Dec 12;13(12):e0208898
pubmed: 30540855
Trends Parasitol. 2013 Apr;29(4):164-80
pubmed: 23415933
Malar J. 2009 Dec 02;8:275
pubmed: 19954537
Lancet. 2005 Sep 17-23;366(9490):1026-35
pubmed: 16168785
BMC Med. 2020 Jan 30;18(1):17
pubmed: 31996199
PLoS Med. 2009 Nov;6(11):e1000188
pubmed: 19936043
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
Malar J. 2019 May 6;18(1):162
pubmed: 31060605
Malar J. 2017 Sep 13;16(1):371
pubmed: 28903758
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
pubmed: 14960256
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004015
pubmed: 20238326
Am J Trop Med Hyg. 2015 Jul;93(1):159-167
pubmed: 25962776
Trop Med Int Health. 2012 Apr;17(4):438-46
pubmed: 22950471
BMC Public Health. 2017 May 18;17(1):470
pubmed: 28521798
Malar J. 2007 May 29;6:72
pubmed: 17535417
Lancet. 1993 Nov 27;342(8883):1317-22
pubmed: 7901634

Auteurs

Beatrice Amboko (B)

KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Kasia Stepniewska (K)

WorldWide Antimalarial Resistance Network, Oxford, United Kingdom.
Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.

Lucas Malla (L)

KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Beatrice Machini (B)

Division of National Malaria Programme, Ministry of Health, Nairobi, Kenya.

Philip Bejon (P)

KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.

Robert W Snow (RW)

KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.

Dejan Zurovac (D)

KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH